When a luxury serum promises that its retinol is "encapsulated for enhanced delivery," the claim rests on one of two very different technologies. Liposomes are microscopic spheres of phospholipid bilayers—structurally similar to the membranes of your own cells—built to help actives interact with skin and carry both water- and oil-soluble compounds. Microcapsules are a core of active ingredient sealed inside a solid polymer shell, built to protect the payload and control when it is released. Understanding that distinction is the single most useful tool a consumer has for judging whether a product's delivery claim is plausible.

Understanding Skincare Delivery Systems

The skin's outermost layer, the stratum corneum, is an exceptionally effective barrier, and many of the most desirable actives—vitamins, retinoids, antioxidants—are chemically fragile, prone to oxidation and degradation long before they reach skin. Encapsulation technologies exist to solve both problems at once: shielding the ingredient during storage and, in some cases, improving how it interacts with the skin surface once applied.

According to Tagra Biotechnologies, a manufacturer of microcapsule systems, the two dominant approaches differ fundamentally in scale and architecture. Microcapsules are micron-sized, roughly 1–1,000 µm, while liposomes run from about 50 nanometers to a few micrometers. A scientific review of lipid-based nano-delivery systems published in the journal Drug Delivery and Translational Research literature notes that the ideal liposome size for delivery purposes falls between 50 and 200 nm, and that size and homogeneity matter more than the number of internal lamellar layers.